Financial Statements

Chemomab Therapeutics Ltd. (CMMB)

$2.8

-0.20 (-6.67%)
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers are in thousands

Retained Earning Schedule

Year 2021 2020
Retained Earnings (Previous Year) -117-
Net Income -12-12
Stock Dividends 93-105
Dividend Paid --
Retained Earnings -36-117

PPE Schedule

Year 2021 2020
Gross PPE 0-
Annual Depreciation 10
Capital Expenditure -0-0
Net PPE 10

Intangible and Goodwill Schedule

Year 2021 2020
Intangible and Goodwill (Previous Year) --
New Purchases --
Intangible and Goodwill --

Chemomab Therapeutics Ltd. income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes Chemomab Therapeutics Ltd. FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.